Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: QORVO BIOTECHNOLOGIES LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-04-02 to 2022-04-01
Current total value of award: $28518139
Description: EO14042 AWARD A CONTRACT FOR RADX TECH - QORVO TO SECURE AN EUA APPROVED POC ANTIGEN TEST SYSTEM AS WELL AS INCREASE AN INCREMENTAL DAILY CARTRIDGE PRODUCTION CAPACITY OF 54,800 TESTS.